Annual report pursuant to Section 13 and 15(d)

Shareholders' Equity (Details)

v3.20.4
Shareholders' Equity (Details) - USD ($)
1 Months Ended 12 Months Ended
Jun. 15, 2020
Jul. 31, 2019
Mar. 31, 2019
Aug. 29, 2018
Dec. 31, 2020
Dec. 31, 2019
Jan. 15, 2020
Shareholders' Equity (Details) [Line Items]              
Total proceeds (in Dollars)         $ 52,000    
Price per share (in Dollars per share)         $ 1.03    
Common stock, shares authorized         25,000,000 12,180,000  
Common stock, shares issued         6,220,927 1,978,269  
Common stock, shares outstanding         6,220,927 1,978,269  
Total intrinsic value (in Dollars)         $ 20,590 $ 0  
Minimum [Member]              
Shareholders' Equity (Details) [Line Items]              
Preferred stock, par value (in Dollars per share)             $ 0.01
Maximum [Member]              
Shareholders' Equity (Details) [Line Items]              
Preferred stock, par value (in Dollars per share)             $ 0.0001
IPO [Member]              
Shareholders' Equity (Details) [Line Items]              
Sale of shares 1,750,000            
Warrants to purchase shares         70,000    
Warrants exercise price (in Dollars per share)         $ 18.75    
Total proceeds (in Dollars) $ 23,419,721            
Underwriting discounts and commissions (in Dollars) 1,968,750            
Other offering expenses (in Dollars) $ 861,529            
Price per share (in Dollars per share) $ 15.00            
Warrants to purchase percentage         125.00%    
Options [Member]              
Shareholders' Equity (Details) [Line Items]              
Common stock for issuance reserved, shares       1,489,680      
Options term         10 years    
Shares remain available for future awards         535,099    
Stock based Compensation (in Dollars)         $ 1,192,000 $ 118,000  
Recognized weighted average period         1 year 109 days    
Weighted average remaining contractual term         8 years 6 months    
Total intrinsic value (in Dollars)         $ 10,726,878    
Intrinsic value, exercisable (in Dollars)         9,773,797    
Expected dividend (in Dollars)         $ 0    
Common Stock [Member]              
Shareholders' Equity (Details) [Line Items]              
Common stock issued relating to stock options         50,460    
Warrant [Member]              
Shareholders' Equity (Details) [Line Items]              
Warrants to purchase shares         325,618 262,003  
Warrants exercise price (in Dollars per share)         $ 6.49 $ 3.13  
Common stock, shares issued         3,350    
Purchase of warrants, shares         4,022    
Additional paid in capital (in Dollars)         $ 36,000 $ 21,000  
Warrant term         003 to 1.003 years.    
Warrant [Member] | Maximum [Member]              
Shareholders' Equity (Details) [Line Items]              
Warrants term           1 year 7 days  
Series A Preferred Stock [Member]              
Shareholders' Equity (Details) [Line Items]              
Preferred stock, shares authorized         1,000,000 3,480,000  
Preferred stock, shares issued     213,510   0 2,438,866  
Preferred stock, shares outstanding         0 2,438,866  
Converted into shares of common stock 2,438,851            
Sale of shares   341,761 590,643        
Aggregate proceeds (in Dollars)   $ 1,070,000 $ 1,850,000   $ 261    
Warrants to purchase shares   41,015 96,499     27,754  
Warrants exercise price (in Dollars per share)   $ 3.13 $ 3.13   $ 3.13    
Common stock, percentage   75.00%          
Liquidation preference amount (in Dollars)           $ 7,639,000  
Preferred stock, par value (in Dollars per share)         $ 0.0001 $ 0.0001  
Stockholders' equity stock split, description In connection with the IPO, all shares of the Company’s Series A Preferred Stock were converted into 2,438,851 shares of common stock, after giving effect to the 1.74 for 1 forward stock split of the common stock and net of the fractional shares adjustments that occurred in connection with the IPO.            
Aggregate of common stock, shares           137,513  
Series A Preferred Stock [Member] | IPO [Member]              
Shareholders' Equity (Details) [Line Items]              
Converted into shares of common stock 2,438,851            
Series A Preferred Stock [Member] | Warrant [Member]              
Shareholders' Equity (Details) [Line Items]              
Warrants to purchase shares           39,651  
Common Stock [Member]              
Shareholders' Equity (Details) [Line Items]              
Warrants to purchase shares         21,360    
Common stock issued relating to stock options         3,350    
Purchase of warrants         4,022    
Common stock, shares authorized         25,000,000 12,180,000  
Common stock, shares issued         6,220,927 1,978,269  
Common stock, shares outstanding         6,220,927    
Unrecognized compensation expense (in Dollars)         $ 2,480,912    
Common Stock [Member] | Warrant [Member]              
Shareholders' Equity (Details) [Line Items]              
Warrants to purchase shares         23,734